A Single Cohort Phase 2 Study of Ruxolitinib in Combinat

Project: Research project

Project Details

Description

A Single Cohort Phase 2 Study of Ruxolitinib in Combination with Corticosteroids for the Treatment of Steroid Refractory Acute Graft vs Host Disease
StatusActive
Effective start/end date6/1/1610/30/21

Funding

  • Incyte Corporation

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.